You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

PAMIDRONATE DISODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Pamidronate Disodium, and what generic alternatives are available?

Pamidronate Disodium is a drug marketed by Aesgen, Am Regent, Areva Pharms, Dr Reddys, Fresenius Kabi Usa, Hikma, Hospira, Mn Pharms, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharma Global, and Teva Pharms Usa. and is included in fourteen NDAs.

The generic ingredient in PAMIDRONATE DISODIUM is pamidronate disodium. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pamidronate Disodium

A generic version of PAMIDRONATE DISODIUM was approved as pamidronate disodium by HIKMA on April 30th, 2001.

  Try a Trial

Drug patent expirations by year for PAMIDRONATE DISODIUM
Recent Clinical Trials for PAMIDRONATE DISODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Peking Union Medical College HospitalPhase 1
The Hospital for Sick ChildrenN/A
National Cancer Institute (NCI)Phase 1

See all PAMIDRONATE DISODIUM clinical trials

Pharmacology for PAMIDRONATE DISODIUM
Drug ClassBisphosphonate

US Patents and Regulatory Information for PAMIDRONATE DISODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 077703-001 Dec 24, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sun Pharma Global PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 077703-002 Dec 24, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aesgen PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 075594-001 May 6, 2002 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 021113-002 Mar 4, 2002 AP1 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Labs Ltd PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 078520-001 Oct 31, 2008 AP2 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.